Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Biological Chemistry|February 25, 2016
The impact of recent advances in genetics in understanding disease mechanisms underlying the long QT syndromesStephen C Harmer, Andrew TinkerExpert Review of Clinical Pharmacology|November 25, 2011
K+ channels in the heart: new insights and therapeutic implicationsAndrew Tinker, Stephen C HarmerEndocrine Research|January 26, 2005
The role of the melanocortin 3 receptor in mediating the effects of gamma-MSH peptides on the adrenalStephen C Harmer, Andrew B BicknellPeptides|June 30, 2005
Role of gamma-MSH peptides in the regulation of adrenal steroidogenesisStephen C Harmer, Andrew B BicknellPharmacology & Therapeutics|February 23, 2017
The control of cardiac ventricular excitability by autonomic pathwaysMalcolm Finlay, Stephen C Harmer, Andrew TinkerPlos One|October 12, 2017
Phosphatidylinositol-4,5-bisphosphate is required for KCNQ1/KCNE1 channel function but not anterograde traffickingAlice A Royal, Andrew Tinker, Stephen C HarmerThe Biochemical Journal|February 8, 2012
Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channelStephen C Harmer, Jagdeep S Mohal, Duncan Kemp, et al.Biochemical and Biophysical Research Communications|February 3, 2022
Identification through action potential clamp of proarrhythmic consequences of the short QT syndrome T618I hERG 'hotspot' mutationChunyun Du, Henggui Zhang, Stephen C Harmer, et al.American Journal of Physiology. Cell Physiology|November 13, 2009
Mechanisms of disease pathogenesis in long QT syndrome type 5Stephen C Harmer, Andrew J Wilson, Robert Aldridge, et al.The Journal of Biological Chemistry|November 19, 2010
Characterization of a binding site for anionic phospholipids on KCNQ1Alison M Thomas, Stephen C Harmer, Tapsi Khambra, et al.Pageof 4